GAROFALO, Carlo
 Distribuzione geografica
Continente #
EU - Europa 2.645
AS - Asia 2.292
NA - Nord America 1.749
SA - Sud America 454
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.182
Nazione #
US - Stati Uniti d'America 1.712
RU - Federazione Russa 1.244
SG - Singapore 752
IE - Irlanda 508
CN - Cina 503
HK - Hong Kong 403
BR - Brasile 380
IT - Italia 260
GB - Regno Unito 157
IN - India 157
KR - Corea 145
VN - Vietnam 129
DE - Germania 126
UA - Ucraina 93
TR - Turchia 74
GR - Grecia 49
FI - Finlandia 38
FR - Francia 38
AT - Austria 36
JP - Giappone 33
CA - Canada 22
AR - Argentina 21
BD - Bangladesh 18
EC - Ecuador 16
BE - Belgio 14
CZ - Repubblica Ceca 14
ES - Italia 14
SE - Svezia 13
IQ - Iraq 12
PH - Filippine 12
CO - Colombia 11
SC - Seychelles 11
PK - Pakistan 10
PL - Polonia 9
MX - Messico 8
PY - Paraguay 8
ID - Indonesia 7
VE - Venezuela 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
NL - Olanda 6
EG - Egitto 5
IR - Iran 5
MA - Marocco 5
UZ - Uzbekistan 5
KZ - Kazakistan 4
LT - Lituania 4
PE - Perù 4
CH - Svizzera 3
CL - Cile 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
RS - Serbia 3
UY - Uruguay 3
IL - Israele 2
MY - Malesia 2
NI - Nicaragua 2
RW - Ruanda 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UG - Uganda 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.182
Città #
Dublin 508
Moscow 417
Hong Kong 403
Santa Clara 352
Singapore 322
Chandler 195
Jacksonville 167
Bengaluru 139
Seoul 137
Hefei 129
Beijing 83
Princeton 67
Roxbury 64
Naples 62
Ashburn 58
Medford 57
New York 55
Dallas 53
Istanbul 52
Munich 44
The Dalles 43
Ho Chi Minh City 41
Ann Arbor 36
São Paulo 35
Saint Petersburg 32
Wilmington 27
Caserta 25
Hanoi 25
Los Angeles 24
Boardman 23
Des Moines 23
Nanjing 23
Bremen 21
Rio de Janeiro 20
Woodbridge 20
Vienna 18
Brussels 14
Nuremberg 14
Brno 13
Jinan 13
Belo Horizonte 12
Houston 12
Milan 12
Turku 11
Cambridge 10
Ercolano 10
Zhengzhou 10
Falkenstein 9
Rome 9
San Mateo 9
Da Nang 8
Haiphong 8
Helsinki 8
Redwood City 8
Curitiba 7
Guayaquil 7
Manaus 7
Napoli 7
Porto Alegre 7
Seattle 7
Shanghai 7
Shenyang 7
Aversa 6
Baghdad 6
Biên Hòa 6
Brooklyn 6
Campinas 6
Dhaka 6
Frankfurt am Main 6
Lappeenranta 6
London 6
Quito 6
Tianjin 6
Tokyo 6
Auburn Hills 5
Changsha 5
Hải Dương 5
Multan 5
Nanchang 5
Ottawa 5
San Francisco 5
Tashkent 5
Warsaw 5
Aracaju 4
Bogotá 4
Columbus 4
Guangzhou 4
Johannesburg 4
Lima 4
Mountain View 4
Ninh Bình 4
San Jose 4
São José dos Campos 4
Toronto 4
Asunción 3
Buenos Aires 3
Capua 3
Casablanca 3
Charlotte 3
Council Bluffs 3
Totale 4.225
Nome #
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 174
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 154
Empagliflozin in Patients with Chronic Kidney Disease 139
Amino acid loss during dialysis treatment 128
[Hyperuricaemia and Chronic Kidney Disease] 117
[Iron deficiency in ND-CKD: from diagnosis to treatment] 116
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 115
[Anti-diabetics and chronic kidney disease] 115
Atherosclerotic-nephropathy: an updated narrative review 115
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 109
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 104
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 102
[Epidemiology and prognosis of chronic kidney disease in Italy] 101
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 98
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 97
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 94
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 93
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 93
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 92
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 88
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 87
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 85
High-flow arteriovenous fistula and heart failure: could the indexation of blood flow rate and echocardiography have a role in the identification of patients at higher risk? 84
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 83
Central Venous Stenosis after Hemodialysis: Case Reports and Relationships to Catheters and Cardiac Implantable Devices 82
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 80
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 79
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment 78
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 77
Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies 77
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD 76
Incremental dialysis in ESRD: systematic review and meta-analysis 75
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 75
Epidemiology of CKD in Italy and prevention strategies 74
[Management of hyperkalemia in Nephrology and Cardiology clinics: reality and perspectives] 74
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 73
Nephroprotection with saxagliptin 73
Dietary salt restriction in chronic kidney disease: A meta-analysis of randomized clinical trials 73
Prevalence and renal prognosis of left ventricular diastolic dysfunction in non-dialysis chronic kidney disease patients with preserved systolic function 73
Effect of post-nephrectomy acute kidney injury on renal outcome: a retrospective long-term study 72
Effect of Increased Convection Volume by Mid-Dilution Hemodiafiltration on the Subclinical Chronic Inflammation in Maintenance Hemodialysis Patients 71
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 70
Sodium intake and chronic kidney disease 70
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 69
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care 69
Statins in patients with chronic kidney disease: new evidence. 67
Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics 67
Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy 67
Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies 65
Exercise training in kidney transplant recipients: a systematic review 65
Sodium toxicity in peritoneal dialysis: mechanisms and "solutions". 65
Current management of hyperkalemia in non-dialysis CKD: Longitudinal study of patients receiving stable nephrology care 65
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 64
Ultrasonography in chronic lithium nephropathy: a case report 64
Recommendations on nutritional intake of potassium in CKD: it's now time to be more flexible! 63
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 63
Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials 62
[Study designs adopted in epidemiology of chronic diseases] 62
Infected hepatic cyst in ADPKD patient in peritoneal dialysis 62
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: The role of kidney 62
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial 62
Role of Ambulatory Blood Pressure Monitoring (ABPM) in chronic kidney patients: a review 61
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease 60
Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer 60
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 59
Remote patient monitoring in dialysis patients: The "change of pace" for home dialysis 59
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 59
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients 59
Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report 58
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 58
Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency 57
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019 57
Nephroprotection by SGLT2 Inhibition: Back to the Future? 57
Limitations of blood pressure target in non-dialysis chronic kidney disease: a question of method ? 56
Role of proteinuria in clinical research: For each old-answer, a new key-question 56
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: A multicohort observational study 55
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis 54
Generalizability of DAPA-CKD trial to the real-world setting of outpatient CKD clinics in Italy 53
SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects 52
Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease 52
Improving Kidney Disease Care: One Giant Leap for Nephrology 51
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 50
Precision Nephrology Is a Non-Negligible State of Mind in Clinical Research: Remember the Past to Face the Future 50
Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care 50
Novel Strategies to Increase Sodium Removal and to Reduce Glucose Exposures in Peritoneal Dialysis 50
Renal Denervation for Resistant Hypertension: Time to Improve Patient Selection. The Lesson From ADPKD 49
Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: Competing risk analysis in older versus younger patients under nephrology care 49
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic 49
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel? 49
Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile 49
Renal involvement in COVID-19: focus on kidney transplant sector 47
No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: a pragmatic, randomized, controlled trial 47
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 46
Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD) 45
Temporal variation of Chronic Kidney Disease's epidemiology 45
Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease 44
Approaches to patients with obesity and CKD: Focus on nutrition and surgery 44
Omics in chronic kidney disease: Focus on prognosis and prediction 42
Sodium-glucose cotransporter-2 inhibition in a CKD patient with severe heart failure treated by high-dose diuretics and peritoneal ultrafiltration: lesson for the clinical nephrologist 41
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 39
Totale 7.186
Categoria #
all - tutte 31.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 4 46 22 15 21 51 2
2021/2022397 18 1 2 5 126 9 8 9 19 27 38 135
2022/2023843 68 14 22 63 70 64 2 32 438 12 23 35
2023/2024477 42 12 22 32 157 50 22 7 12 7 41 73
2024/20251.746 11 31 16 78 295 252 282 141 211 198 129 102
2025/20262.993 344 456 342 339 561 951 0 0 0 0 0 0
Totale 7.401